We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QEWS:QSENebras Energy Analysis

Data as of 2026-05-24 - not real-time

QAR 14.44

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Price action: QEWS is trading at QAR 14.44, below its 20‑day (14.67) and 50‑day (14.62) SMAs and just above the identified support level of 14.35, indicating short‑term pressure. Technical indicators reinforce this view – RSI sits at 40.5 (near‑oversold) and the MACD histogram is negative, signaling bearish momentum.
Valuation & yield: The stock’s PE of 11.6 is well under the industry average of 22, and the PB of 1.04 hovers around book value, suggesting relative cheapness. However, the DCF‑derived fair value of 11.17 is below the current price, implying a modest overvaluation on an intrinsic basis. The dividend yield is an attractive 7% with a low payout ratio (≈20%), supporting income‑focused investors. Fundamentals: Revenue growth is healthy at 7.7% YoY, but free cash flow is negative and debt‑to‑equity is high (45.3), flagging balance‑sheet pressure. Analyst consensus (4 analysts) is bullish with a mean target of QAR 19.58, indicating upside potential of over 30%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above support with limited upside
  • Bearish MACD and neutral trend suggest limited short‑term rally
  • Increasing volume could accelerate a move lower if sentiment turns negative

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst price targets imply ~35% upside
  • Attractive dividend yield and low payout ratio support total return
  • PE and PB are well below industry averages, indicating valuation headroom

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Regulated utility business provides stable cash flows
  • High debt‑to‑equity and negative free cash flow pose balance‑sheet risk
  • Sustainable dividend and low beta make it suitable for defensive portfolios

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin45.99%
P/E Ratio11.6
ROE8.96%
ROA1.98%
Debt/Equity45.28
P/B Ratio1.0
Op. Cash FlowQAR1.3B
Free Cash FlowQAR-943811136
Industry P/E22.0

Technical Analysis

TrendNeutral
RSI40.5
SupportQAR 14.35
ResistanceQAR 15.18
MA 20QAR 14.67
MA 50QAR 14.62
MA 200QAR 15.27
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair ValueQAR 11.17
Target PriceQAR 19.58
Upside/Downside35.56%
GradeFair
TypeValue
Dividend Yield7.01%

Risk Assessment

Beta0.19
Volatility11.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.